Jeremy Grantham's EXEL Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 11,849 shares of Exelixis, Inc. (EXEL) worth $489,364, representing 0.00% of the portfolio. First purchased in 2018-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in EXEL, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 83,897 shares. Largest reduction occurred in Q1 2025, reducing 151,153 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Exelixis (EXEL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exelixis (EXEL) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2018 | +26,300 | New Buy | 26,300 | $22.17 |
| Q2 2018 | +4,700 | Add 17.87% | 31,000 | $21.52 |
| Q3 2018 | -31,000 | Sold Out | 0 | $0.00 |
| Q2 2022 | +18,100 | New Buy | 18,100 | $20.83 |
| Q3 2022 | +3,800 | Add 20.99% | 21,900 | $15.66 |
| Q4 2022 | +75,200 | Add 343.38% | 97,100 | $16.04 |
| Q1 2023 | -97,100 | Sold Out | 0 | $0.00 |
| Q3 2024 | +83,897 | New Buy | 83,897 | $25.95 |
| Q4 2024 | +67,256 | Add 80.16% | 151,153 | $33.30 |
| Q1 2025 | -151,153 | Sold Out | 0 | $0.00 |
| Q3 2025 | +11,849 | New Buy | 11,849 | $41.30 |
Jeremy Grantham's Exelixis Investment FAQs
Jeremy Grantham first purchased Exelixis, Inc. (EXEL) in Q1 2018, acquiring 26,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Exelixis, Inc. (EXEL) for 11 quarters since Q1 2018.
Jeremy Grantham's largest addition to Exelixis, Inc. (EXEL) was in Q3 2024, adding 83,897 shares worth $2.18 M.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 11,849 shares of Exelixis, Inc. (EXEL), valued at approximately $489,364.
As of the Q3 2025 filing, Exelixis, Inc. (EXEL) represents approximately 0.00% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Exelixis, Inc. (EXEL) was 151,153 shares, as reported at the end of Q4 2024.